These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 37470682)

  • 1. Concurrent disorders of cats with diabetes mellitus and arterial systolic hypertension.
    Williams JG; Hess RS
    J Feline Med Surg; 2023 Jul; 25(7):1098612X231187691. PubMed ID: 37470682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.
    Glaus TM; Elliott J; Herberich E; Zimmering T; Albrecht B
    J Vet Intern Med; 2019 Mar; 33(2):413-422. PubMed ID: 30561059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized placebo-controlled clinical trial of a chewable formulation of amlodipine for the treatment of hypertension in client-owned cats.
    Huhtinen M; Derré G; Renoldi HJ; Rinkinen M; Adler K; Aspegrén J; Zemirline C; Elliott J
    J Vet Intern Med; 2015; 29(3):786-93. PubMed ID: 25857394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
    Ward JL; Guillot E; Domenig O; Ware WA; Yuan L; Mochel JP
    J Vet Intern Med; 2022 May; 36(3):897-909. PubMed ID: 35285549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
    Jepson RE; Syme HM; Elliott J
    J Vet Intern Med; 2014; 28(1):144-53. PubMed ID: 24428319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of systemic hypertension in cats with amlodipine besylate.
    Henik RA; Snyder PS; Volk LM
    J Am Anim Hosp Assoc; 1997; 33(3):226-34. PubMed ID: 9138233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats.
    Bijsmans ES; Doig M; Jepson RE; Syme HM; Elliott J; Pelligand L
    J Vet Intern Med; 2016 Sep; 30(5):1630-1636. PubMed ID: 27717190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of control of systolic blood pressure on survival in cats with systemic hypertension.
    Jepson RE; Elliott J; Brodbelt D; Syme HM
    J Vet Intern Med; 2007; 21(3):402-9. PubMed ID: 17552443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases.
    Elliott J; Barber PJ; Syme HM; Rawlings JM; Markwell PJ
    J Small Anim Pract; 2001 Mar; 42(3):122-9. PubMed ID: 11303854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of amlodipine in the treatment of cats with systemic hypertension in Japan.
    Morita S; Mochizuki Y; Matsumoto I; Horii A; Ohmori T; Hirao D; Hasegawa H; Yoshimura A; Baba T; Suzuki S; Fukushima R
    J Vet Med Sci; 2024 May; 86(5):533-541. PubMed ID: 38569838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline comorbidities: The intermingled relationship between chronic kidney disease and hypertension.
    Lawson JS; Jepson RE
    J Feline Med Surg; 2021 Sep; 23(9):812-822. PubMed ID: 34428941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension.
    Snyder PS; Sadek D; Jones GL
    J Vet Intern Med; 2001; 15(1):52-6. PubMed ID: 11215913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular fundus abnormalities in cats affected by systemic hypertension: Prevalence, characterization, and outcome of treatment.
    Cirla A; Drigo M; Andreani V; Barsotti G
    Vet Ophthalmol; 2021 Mar; 24(2):185-194. PubMed ID: 33512084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of atenolol as a single antihypertensive agent in hyperthyroid cats.
    Henik RA; Stepien RL; Wenholz LJ; Dolson MK
    J Feline Med Surg; 2008 Dec; 10(6):577-82. PubMed ID: 18955003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of ocular lesions associated with hypertension in a population of geriatric cats in Auckland, New Zealand.
    Carter JM; Irving AC; Bridges JP; Jones BR
    N Z Vet J; 2014 Jan; 62(1):21-9. PubMed ID: 24138677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Efficacy of Antihypertensive Drugs in Dogs: A Systematic Review.
    Choi HI; Kim J; Shin IS; Kim HJ
    Top Companion Anim Med; 2022; 50():100674. PubMed ID: 35640871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats.
    Kurtz M; Fabrès V; Dumont R; Chetboul V; Chahory S; Saponaro V; Trehiou E; Poissonnier C; Passavin P; Jondeau C; Bott M; Buronfosse T; Benchekroun G
    J Vet Intern Med; 2023; 37(4):1348-1357. PubMed ID: 37246725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.
    Coleman AE; Brown SA; Traas AM; Bryson L; Zimmering T; Zimmerman A
    J Vet Intern Med; 2019 Mar; 33(2):478-488. PubMed ID: 30851066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.